Ivermectin does not speed symptom resolution in mild COVID-19
(HealthDay)—A five-day course of ivermectin does not improve the time to resolution of symptoms compared with placebo for adults with mild COVID-19, according to a study published online March 4 in the Journal of the American Medical Association.